logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
15/10/2026
New York futures gold breaks through $4,130/oz, up 0.54% intraday.
Latest
4 m ago
The announcement shows that Iambic Therapeutics, a clinical-stage oncology drug development and technology company in which Nvidia (NVDA.O) holds a stake, completed its U.S. initial public offering, raising $150 million, with the offering price set at the midpoint of its marketed range. Iambic sold approximately 9.38 million shares at $16 per share. A previous filing showed that Iambic had originally set a price range of $15 to $17 per share. Based on the IPO price and the issued shares disclosed in the filing, the company has a market value of $758 million. The filing shows that Iambic uses artificial intelligence and machine learning technologies to develop new therapies. The company will use the proceeds from the IPO to advance three early-stage oncology drug candidates.
9 m ago
XPeng Motors (XPEV.N) Chairman He Xiaopeng called for deeper global cooperation at the 2026 Paris Automotive Summit, highlighting "XPeng AI Engineering."
9 m ago
Nvidia-backed AI drug discovery company Iambic prices IPO at $16, expected to raise $150 million.
10 m ago
Shinhan Financial plans to spend 1.2 trillion won to acquire Lotte's non-life insurance business
10 m ago
Dividend fund net values collectively approach new highs, with three major factors driving the strength.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.